RC-160 (Vapreotide),CAS:103222-11-3
RC-160 (Vapreotide)
Product description
The somatostatin analog. Re-188-RC-160 (radioisotope RheniuM-188-labeled RC-160) has been successfully used for the local/regional treatment of experimental breast cancer and other cancers.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Cas | 103222-11-3 |
| Sequence | H-DPhe-Cys-Tyr-DTrp-Lys-Val-Cys-Trp-NH2 (trifluoroacetate salt) (Cys2 and 7 bridge) |
| One letter sequence | fCYwKVCW-NH2 (C2&C7 bridge) |
| Molecular formula | C57H72N12O9S2 |
| Storage | -20℃,protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of RC-160 (Vapreotide)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


